Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Liberty Health Sciences Inc CSE: LHS-CN

Today's Change
Real-Time Last Update CSE Last Sale

Today's Trading

Day Low 1.400
Day High 1.500
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Liberty Health Sciences Inc is committed to delivering pharmaceutical-grade cannabis to patients. The company produces pharmaceutical-grade marijuana. It operates in the United States and Canada. The company generated most of its revenue from dispensary customers.


Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio


Corporate earnings are provided from Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

No rating

Latest Press Releases

Liberty Health Sciences Announces the Opening of its 30th and 31st Dispensary in Florida
- PR Newswire - PRF - Wed Feb 24, 7:13AM CST
PR Newswire - PRF - CMTX
Wed Feb 24, 7:13AM CST
, /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) ("Liberty" or the "Company"), a provider of high-quality cannabis, announced today the opening of its 30th dispensary in in . The facility is located at 4656 Tamiami Trail, 33980. Operating hours are Monday through Friday, , Saturday, , and Sunday,
Liberty Announces Results of Voting at Special Meeting of Securityholders
- PR Newswire - PRF - Tue Feb 23, 2:04PM CST
PR Newswire - PRF - CMTX
Tue Feb 23, 2:04PM CST
, /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: ) ("Liberty" or the "Company"), a provider of high-quality cannabis, is pleased to announce that at today's special meeting of the securityholders (the "Meeting"), holders of the common shares (the "Liberty Shareholders") and holders of options of Liberty (together with the Liberty Shareholders, the "Liberty Securityholders") approved the arrangement resolution (the "Arrangement Resolution") under which Ayr Wellness Inc. ("Ayr") will acquire all of the issued and outstanding shares (the "Liberty Shares") of Liberty in a transaction originally announced on (the "Arrangement").
Leading Independent Proxy Advisory Firm ISS Recommends Liberty Health Science Shareholders Vote "FOR" Proposed Acquisition by Ayr
- PR Newswire - PRF - Thu Feb 11, 6:47PM CST
PR Newswire - PRF - CMTX
Thu Feb 11, 6:47PM CST
, /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) ("Liberty" or the "Company"), a provider of high-quality cannabis, today announced that leading independent proxy advisory firm, Institutional Shareholder Services ("ISS"), recommends that Liberty shareholders vote "FOR" the shareholder proposal relating to Ayr Strategies Inc.'s (CSE:AYR.A, OTCQX: AYRWF) ("Ayr") proposed acquisition of Liberty Health Sciences.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 1.060 +38.68% increase
on 01/27/21
Period Open:1.200
Price movement based on the high, low and last over the given period.
1.550 -5.16% decrease
on 02/10/21
+0.270 (+22.50%) increase
since 01/26/21
3-Month 0.470 +212.77% increase
on 12/11/20
Period Open:0.495
Price movement based on the high, low and last over the given period.
1.550 -5.16% decrease
on 02/10/21
+0.975 (+196.97%) increase
since 11/26/20
52-Week 0.320 +359.38% increase
on 03/16/20
Period Open:0.520
Price movement based on the high, low and last over the given period.
1.550 -5.16% decrease
on 02/10/21
+0.950 (+182.69%) increase
since 02/26/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies